Active, not recruitingPhase 3NCT03040778

Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ)

Studying Avascular necrosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Washington
Principal Investigator
Jasjit Dillon, DDS, MBBS
University of Washington
Intervention
Pentoxifylline(drug)
Enrollment
100 enrolled
Eligibility
18-90 years · All sexes
Timeline
2018 – 2026

Study locations (4)

Collaborators

University of Alabama at Birmingham · New York Center for Orthognathic and Maxillofacial Surgery · University of Michigan

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03040778 on ClinicalTrials.gov

Other trials for Avascular necrosis

Additional recruiting or active studies for the same condition.

See all trials for Avascular necrosis →

← Back to all trials